|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
3,780,000 |
Market
Cap: |
10.77(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.55 - $3.36 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AYTU BioPharma is a pharmaceutical company focused on commercializing therapeutics and consumer health products and developing therapeutics for pediatric-onset or difficult-to-treat diseases. Co. operates through two business segments: the BioPharma segment, consisting of prescription pharmaceutical products; and the Consumer Health segment, which consists of various consumer healthcare products. Co. also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
538,371 |
Total Buy Value |
$0 |
$0 |
$0 |
$148,920 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
5 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pyszczymuka Greg |
Chief Commercial Officer |
|
2024-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,768 |
|
- |
|
Pyszczymuka Greg |
Chief Commercial Officer |
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
209 |
22,560 |
|
- |
|
Pyszczymuka Greg |
Chief Commercial Officer |
|
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,351 |
|
- |
|
Jain Abhinav |
|
|
2023-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
8,000 |
|
- |
|
Liu Vivian H |
|
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
1,841 |
|
- |
|
Donofrio John Jr. |
|
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
2,262 |
|
- |
|
Jain Abhinav |
|
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
1,500 |
|
- |
|
Dockery Carl |
|
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
8,940 |
|
- |
|
Pyszczymuka Greg |
Chief Commerical Officer |
|
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
208 |
22,143 |
|
- |
|
Disbrow Joshua R. |
Chief Executive Officer |
|
2023-06-14 |
4 |
B |
$1.86 |
$26,079 |
D/D |
14,000 |
71,591 |
0.01 |
68% |
|
Mack Daniel |
10% Owner |
|
2023-06-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,086,812 |
|
76% |
|
Liu Vivian H |
Director |
|
2023-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
6,825 |
|
- |
|
Pyszczymuka Greg |
Chief Commercial Officer |
|
2022-12-19 |
4 |
B |
$0.24 |
$24,480 |
D/D |
100,000 |
182,056 |
2.74 |
-47% |
|
Disbrow Joshua R. |
Chief Executive Officer |
|
2022-12-19 |
4 |
B |
$0.22 |
$25,047 |
D/D |
112,371 |
1,231,877 |
2.81 |
-47% |
|
Disbrow Joshua R. |
Chief Executive Officer |
|
2022-11-18 |
4/A |
B |
$0.24 |
$52,614 |
D/D |
222,000 |
1,119,506 |
2.81 |
- |
|
Oki Mark K |
Chief Financial Officer |
|
2022-11-18 |
4/A |
B |
$0.23 |
$20,700 |
D/D |
90,000 |
190,000 |
2.74 |
- |
|
Oki Mark K |
Chief Financial Officer |
|
2022-11-18 |
4 |
A |
$0.23 |
$20,700 |
D/D |
90,000 |
190,000 |
|
- |
|
Disbrow Joshua R. |
Chief Executive Officer |
|
2022-11-18 |
4 |
A |
$0.24 |
$52,614 |
D/D |
222,000 |
1,119,506 |
|
- |
|
Pyszczymuka Greg |
Chief Commercial OfficerOffice |
|
2022-11-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
82,056 |
|
-45% |
|
Disbrow Jarrett |
Chief Business OfficerOfficer |
|
2022-11-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
255,949 |
|
-45% |
|
Brooke Christopher |
Chief Operating OfficerOfficer |
|
2022-11-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,167,147 |
|
-45% |
|
Liu Vivian H |
Director |
|
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
6,500 |
|
- |
|
Oki Mark K |
Chief Financial Officer |
|
2022-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
Macaluso Michael |
Director |
|
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
187,804 |
208,079 |
|
- |
|
Dockery Carl |
Director |
|
2021-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
187,804 |
188,805 |
|
- |
|
116 Records found
|
|
Page 1 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|